Information for "Template:Oral hypoglycemics and insulin analogs"

Basic information

Display title	Template:Oral hypoglycemics and insulin analogs
Default sort key	Oral hypoglycemics and insulin analogs
Page length (in bytes)	2,029
Namespace ID	10
Namespace	Template
Page ID	100470
Page content language	en - English
Page content model	wikitext
Indexing by robots	Allowed
Number of redirects to this page	1

Edit	Allow all users (infinite)
Move	Allow all users (infinite)

Page creator	Vandals (talk \| contribs)
Date of page creation	09:42, 21 January 2011
Latest editor	C Michael Gibson (talk \| contribs)
Date of latest edit	12:08, 21 January 2011
Total number of edits	2
Total number of distinct authors	2
Recent number of edits (within past 30 days)	0
Recent number of distinct authors	0

Transcluded templates (6)	Templates used on this page: Template:Navbox (view source) Module:Arguments (view source) Module:Color contrast (view source) Module:Color contrast/colors (view source) Module:Navbar (view source) Module:Navbox (view source)
Pages transcluded on (20)	Templates used on this page: Alpha-glucosidase inhibitor (view source) (protected) Benfluorex (view source) (protected) Biguanide (view source) (protected) Glibornuride (view source) (protected) Gliclazide (view source) (protected) Glipizide detailed information (view source) (protected) Glisoxepide (view source) (protected) Glucagon-like peptide-1 analog (view source) (protected) Insulin analog (view source) (protected) Insulin lispro (view source) Meglitinide (view source) (protected) Metahexamide (view source) (protected) Muraglitazar (view source) NPH insulin (view source) (protected) Tesaglitazar (view source) The Living Textbook of Endocrinology (view source) The WikiDoc Living Textbook of Endocrinology (view source) Thiazolidinedione (view source) (protected) Troglitazone (view source) (protected) Voglibose (view source) (protected)